{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:53:26Z","timestamp":1767480806250,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.biopha.2003.08.001","type":"journal-article","created":{"date-parts":[[2003,9,11]],"date-time":"2003-09-11T22:30:24Z","timestamp":1063319424000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pure red cell aplasia\u2014a rare disease with multiple causes"],"prefix":"10.1016","volume":"57","author":[{"given":"M","family":"Djaldetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2003.08.001_BIB1","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood.V100.8.2687","article-title":"Response of Diamond\u2013Blackfan anemia to metoclorpramide: evidence for a role for prolactin in erythropoiesis","volume":"100","author":"Abkowitz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2141.2002.3317_3.x","article-title":"Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment","volume":"116","author":"Auner","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative haematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200202143460711","article-title":"Drug-Induced autoimmune red cell aplasia","volume":"346","author":"Bun","year":"2002","journal-title":"New Engl J M"},{"issue":"Suppl 5","key":"10.1016\/j.biopha.2003.08.001_BIB5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/17.suppl_5.42","article-title":"Antibodies against rHuEPO: native and recombinant","volume":"17","author":"Casadevall","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB6","first-page":"1547","article-title":"Erythropoiesis disorders and other central autoimmune anemias","volume":"51","author":"Casadevall","year":"2001","journal-title":"Rev Prat"},{"key":"10.1016\/j.biopha.2003.08.001_BIB7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Brief report: autoantibodies against erythropoietin in a patient with pure red cell aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB9","first-page":"9","article-title":"Relapsing pure red cell aplasia associated with B\u2013cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate","volume":"17","author":"Castelli","year":"2002","journal-title":"Ann Ital Med Int"},{"key":"10.1016\/j.biopha.2003.08.001_BIB10","first-page":"655","article-title":"Pure red cell aplasia associated with carbazepine","volume":"46","author":"Chandra","year":"1998","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.biopha.2003.08.001_BIB11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3349\/ymj.2002.43.2.274","article-title":"Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus","volume":"43","author":"Choi","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.biopha.2003.08.001_BIB12","first-page":"342","article-title":"Pure red cell aplasia","author":"Dessypris","year":"2000"},{"key":"10.1016\/j.biopha.2003.08.001_BIB13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1702992","article-title":"Recovery of erythropoiesis following bone marrow transplantation for chronic lymphocytic leukaemia-associated pure red cell aplasia","volume":"27","author":"De-Vetten","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3109\/10428190109097772","article-title":"Clonality of pure red cell aplasia: effectiveness of antithymocyte globulin","volume":"42","author":"Dincol","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.biopha.2003.08.001_BIB15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1542\/peds.110.4.e44","article-title":"Study of 22\u00a0Egyptian patients with Diamond\u2013Blackfan anemia, corticosteroids, and cyclosporin therapy results","volume":"110","author":"El-Beshlawy","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopha.2003.08.001_BIB16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.10024","article-title":"T-gamma large granular lymphocyte leukemia associated with amegakaryocytic purpura, Sjogren\u2019s syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia","volume":"69","author":"Ergas","year":"2002","journal-title":"Am J Hermatol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.1996.tb00996.x","article-title":"Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin","volume":"9","author":"Fujisawa","year":"1996","journal-title":"Transplant Int"},{"key":"10.1016\/j.biopha.2003.08.001_BIB18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature","volume":"14","author":"Geetha","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB19","first-page":"198","article-title":"Lack of erythropoietic inhibitory effect of serum from patients with congenital pure red cell aplasia","volume":"292","author":"Geller","year":"1975","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB20","first-page":"346","article-title":"Pure red cell aplasia and recombinant erythropoietin","author":"Gershon","year":"2002","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","article-title":"Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia","volume":"99","author":"Ghasal","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/10428190127501","article-title":"Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia","volume":"42","author":"Grigg","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.biopha.2003.08.001_BIB24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/sarh.2002.30440","article-title":"Pure red cell aplasia and lupus","volume":"31","author":"Habib","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.biopha.2003.08.001_BIB25","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V100.8.2724","article-title":"Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond\u2013Blackfan syndrome","volume":"100","author":"Hamaguchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2257.2000.00278.x","article-title":"Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-alpha","volume":"22","author":"Hirri","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1345\/aph.1A115","article-title":"High-dose methylprednisolone therapy in pure red cell aplasia","volume":"36","author":"Kadikoylu","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.biopha.2003.08.001_BIB28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/10428190109064614","article-title":"Epstein\u2013Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia","volume":"42","author":"Katayama","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.biopha.2003.08.001_BIB29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000064456","article-title":"Pure red cell aplasia preceding malignant lymphoma in a renal transplant patient","volume":"92","author":"Kiykim","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2003.08.001_BIB30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/108729100318082","article-title":"Parvovirus B19-related anemia in HIV-infected patients","volume":"1","author":"Koduri","year":"2000","journal-title":"AIDS Patient Care"},{"key":"10.1016\/j.biopha.2003.08.001_BIB31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/10428190127513","article-title":"Pure red cell aplasia associated with parvovirus B19 infection in T-large granular lymphocyte leukemia","volume":"42","author":"Kondo","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.biopha.2003.08.001_BIB32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1973.tb01710.x","article-title":"Pure red cell aplasia","volume":"25","author":"Krantz","year":"1973","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB33","first-page":"3450","article-title":"Pure red cell aplasia","volume":"291","author":"Krantz","year":"1974","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB34","first-page":"259","article-title":"Pure red cell aplasia associated with thymoma","volume":"44","author":"Lahiri","year":"2002","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.biopha.2003.08.001_BIB35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-0609.2000.9c212.x","article-title":"Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins","volume":"65","author":"Larroche","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB36","first-page":"1474","article-title":"Wintrobe\u2019s Clinical Hematology","author":"Lee","year":"1999"},{"key":"10.1016\/j.biopha.2003.08.001_BIB37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1702121","article-title":"Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation","volume":"25","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03009749950154293","article-title":"Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin","volume":"28","author":"Linardaki","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1096-8652(200011)65:3<189::AID-AJH2>3.0.CO;2-6","article-title":"Lamivudine-induced pure red cell aplasia","volume":"65","author":"Majluf-Gruz","year":"2000","journal-title":"Am J Hematol"},{"issue":"4\u00a0Suppl 2","key":"10.1016\/j.biopha.2003.08.001_BIB40","first-page":"S3","article-title":"Erythropoietin: biochemical characteristics, biological effects, indications and results of use in hematology","volume":"83","author":"Marmont","year":"1997","journal-title":"Tumori"},{"key":"10.1016\/j.biopha.2003.08.001_BIB41","first-page":"456","article-title":"Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin","volume":"79","author":"Martelli","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2003.08.001_BIB42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/tropej\/48.2.113","article-title":"Clinico-haematological profile of pure red cell aplasia in children","volume":"48","author":"Marwaha","year":"2002","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.biopha.2003.08.001_BIB43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703668","article-title":"Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia","volume":"6","author":"Maschan","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2169\/internalmedicine.40.802","article-title":"Successful therapy of pure red cell aplasia secondary to plasma cell dyscrasia with bolus methylprednisolone","volume":"40","author":"Matsuhashi","year":"2001","journal-title":"Intern M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB45","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM198710153171606","article-title":"Treatment of antibody-mediated pure red cell aplasia with high-dose intravenous gamma globulin","volume":"317","author":"McGuire","year":"1987","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB46","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1086\/340982","article-title":"Linezolid-induced pure red blood cell aplasia","volume":"35","author":"Monson-Thomas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biopha.2003.08.001_BIB47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM197810052991418","article-title":"Reversible pure red cell aplasia in pregnancy","volume":"299","author":"Miyoshi","year":"1978","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/021849230201000213","article-title":"Thymoma associated with pure red cell aplasia: clinical features and prognosis","volume":"10","author":"Murakawa","year":"2002","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.biopha.2003.08.001_BIB49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000053004","article-title":"Pure red cell aplasia and acute hepatitis during pregnancy","volume":"53","author":"Ohno","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.biopha.2003.08.001_BIB50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2169\/internalmedicine.41.589","article-title":"A patient with acquired pure red cell aplasia showing a positive antiglobulin test and the presence of inhibitor against erythroid precursors","volume":"41","author":"Okoshi","year":"2002","journal-title":"Intern M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB51","first-page":"2166","article-title":"Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin","volume":"22","author":"Orbach","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1537-2995.1993.33593255604.x","article-title":"Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin","volume":"33","author":"Paltiel","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.biopha.2003.08.001_BIB53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJM198407193110319","article-title":"Relapsing pure red cell aplasia during pregnancy","volume":"311","author":"Picot","year":"1984","journal-title":"New Engl J M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0003-4975(00)02313-4","article-title":"Concomitant thymectomy and cardiac operation in a patient with pure red cell aplasia","volume":"72","author":"Poullis","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.biopha.2003.08.001_BIB55","first-page":"331","article-title":"Antibodies against human erythropoietin causing pure red cell aplasia","volume":"47","author":"Prabhakar","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajh.2830460109","article-title":"Pure red cell aplasia after chemotherapy for Hodgkin\u2019s lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietin","volume":"46","author":"Reid","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1701012","article-title":"Successful treatment of pure red cell aplasia after major ABO-incompatible T-cell depleted bone marrow transplantation with erythropoietin","volume":"20","author":"Santamaria","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB58","first-page":"37","article-title":"Acquired pure red cell aplasia in a child","volume":"48","author":"Sharma","year":"2002","journal-title":"J Postgrad M"},{"key":"10.1016\/j.biopha.2003.08.001_BIB59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V96.3.1184.015k54_1184_1186","article-title":"Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab","volume":"96","author":"Sharma","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB60","first-page":"1123","article-title":"Non-Hodgkin\u2019s lymphoma with pure red cell aplasia","volume":"49","author":"Singh","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.biopha.2003.08.001_BIB61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2141.2002.03778.x","article-title":"Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma","volume":"119","author":"Song","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001813-200101000-00002","article-title":"Interferon-alpha-induced pure red cell aplasia following chronic myelogeneous leukemia","volume":"12","author":"Tomit","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2003.08.001_BIB63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.bmt.1702629","article-title":"Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning","volume":"26","author":"Veelken","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.biopha.2003.08.001_BIB64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/345745","article-title":"Severe prolonged blood cell aplasia and thrombocytopenia induced by parvovirus infection B19 infection in a patient with sarcoidosis","volume":"36","author":"Viallard","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biopha.2003.08.001_BIB65","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000027031.79843.6C","article-title":"Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoietins","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/stem.5530100502","article-title":"The human erythropoietin receptor","author":"Winkelmann","year":"1992","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.biopha.2003.08.001_BIB67","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF02982116","article-title":"Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy","volume":"75","author":"Yamauchi","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002770000275","article-title":"Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review","volume":"80","author":"Yang","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB69","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V97.12.3995","article-title":"Anti-CD20 monoclonal antibody for treatment of severe, immune-mediated pure red cell aplasia and hemolytic anemia","volume":"97","author":"Zecca","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2003.08.001_BIB70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.1993.tb04626.x","article-title":"Resolution of transfusion dependence by human recombinant erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia","volume":"83","author":"Zeigler","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2003.08.001_BIB71","first-page":"61","article-title":"Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Zhu","year":"2002","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.biopha.2003.08.001_BIB72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1423-0410.2000.7820126.x","article-title":"Splenic lymphoma presenting as warm autoimmune hemolytic anemia associated with pure red cell aplasia","volume":"78","author":"Zeidman","year":"2000","journal-title":"Vox Sang"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332203001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332203001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:29:14Z","timestamp":1760092154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332203001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0753332203001033"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2003.08.001","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pure red cell aplasia\u2014a rare disease with multiple causes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2003.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}